University of Missouri School of Medicine MU Health School of Medicine
Faculty Photo - Mohan, Rajiv R., PhD

Rajiv R. Mohan, PhD

Professor of Ophthalmology
Resident Research Coordinator

  • E-mail: MohanR@health.missouri.edu
  • Phone: (573) 884-1449
  • Fax: (573) 884 - 4100 and  (573) 814-6551
  • Office: One Hospital Dr., Ste. EC210

Background

  • B.Sc. - Lucknow University, India. Chemistry, Zoology and Botany
  • M. Sc. - Lucknow University, India. Synthetic Organic and Medicinal Chemistry
  • Ph. D. - Lucknow University, India. Medicinal Chemistry
  • Postdoctoral Training: Case University, Cleveland, Ohio (1993-1995), Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio (1995-1998) and University of Washington, Seattle, Washington (1998-2001)

Professional Courses

  • Research Management: Center for Medical Education Research and Development, Cleveland Clinic, Cleveland, Ohio. Instructor: Alan L. Hull, M.D., Ph. D. (Feb-May, 2005)
  • Introduction to Clinical Research: Center for Medical Education Research and Development, Cleveland Clinic, Cleveland, Ohio. Instructor: Ralph O'Brien, Ph. D. (Jan-May, 2005)

Editorial Board Member of Scientific Journals

  • 2011 - present   Translational Vision Science and Technology
  • 2011 - present   Cloning and Transgenesis
  • 2011 - present   ISRN Ophthalmology
  • 2011 - present   World Journal of Experiemental Medicine
  • 2010 - present   PlosOne
  • 2009 - present   Nanomedicine: Nanotechnology, Biology and Medicine
  • 2008 - present   Journal of Refractive Surgery
  • 2008 - present   Journal of Cell Death
  • 2001 - present   Journal of Toxicology Cutaneous and Ocular Toxicology, USA
  • 1989 - 1994        Journal of Indian Council of Chemists, Agra, India

Ad-hoc reviewer of Scientific Journals

  • Investigative Ophthalmology & Visual Science
  • Experimental Eye Research
  • Molecular Vision
  • Journal of Refractive Surgery
  • Journal of Cataract and Refractive Surgery
  • Cornea
  • Current Eye Research
  • Archives of Ophthalmology
  • Ophthalmic Research
  • Open Ophthalmology Journal
  • Eye and Contact Lens
  • Biomaterials
  • Journal of Cellular Biochemistry
  • Molecular Medicine
  • Cellular and Molecular Medicine
  • Ophthalmic Research
  • Journal of Gene Medicine
  • Brain Research Bulletin
  • Journal of Neouroimmunobiology
  • Japanese Journal of Ophthalmology
  • CNS & Neurological Disorders Drug Targets
  • Journal of Veterinary Science and Technology
  • Photochemistry and Photobiology
  • Open access journal
  • Journal of Neurochemistry

Awards & Honors

2012

  • 2012 - Newest and Most Innovative Research Award by the Association for Research in Vision and Ophthalmology (ARVO) appeared in "Hot Topics and Emerging Trends" (May 6; Abstract #294)
  • 2012 - Chair, Nanotechnology and Regenerative Medicine Paper Session (May 2)
  • 2012 - Research Presentation Award to Kevin Donnelly at the 35th Annual Phi Zeta Research Day (May 4)
  • 2012 - Outstanding Discovery Fellow Award to Audra Stallard (April 9)
  • 2012 - Distinguished Invited speaker at the Central Drug Research Institute, India (Feb 14)
  • 2012 - Invited Speaker at the World Ophthalmology Congress, Abu Dhabi (Feb 17)
  • 2012 - Co-chair, New Technology Section, World Ophthalmology Congress, Abu Dhabi (Feb 17)
  • 2012 - National Eye Institute, NIH Travel Award. Abstract #294 (Jason Rodier MD)
  • 2012 - ARVO Organizing Committee (Nanotechnology and Regenerative Medicine)
  • 2012 - Co-chair, ARVO Nanotechnology and Regenerative Medicine Platform Session (May 1)

2011

  • 2011 - Phi Zeta Award (Kevin Donnelly DVM: Mentor Rajiv Mohan)
  • 2011 - Missouri Foundation Medical Research Award (Jason Rodier MD, Mentor: Rajiv Mohan)
  • 2011 - Invited talk at the International Society for Ocular Cell Biology of the ARVO (Sept 7-10)
  • 2011 - Invited guest lecture at Daekin University, Geelong, Australia (July 18)
  • 2011 - Invited talk at Sydney International Nanomedicine Conference, Sydney Australia (July 14-16)
  • 2011 - Best Research Paper Award, 18th Mason Eye Institute Alumni Day (June 3; Nathan Hesemann)
  • 2011 - Missouri Foundation for Medical Research Best Poster Award at VA Research Week (May 4)
  • 2011 - ARVO Newest and most innovative research. Abstract # 3045 appeared in "Hot Topics and Emerging Trends" (May 3)
  • 2011 - Invited talk at the ARVO symposium on "Versatile functions of small leucine rich repeat proteoglycan family: implications in corneal inflammation, infection and tissue bioengineering" (May 3)
  • 2011 - Abstract #7231 received National Eye Institute, NIH Travel Award (Eric Hansen)
  • 2011 - Moderator "Nanotechnology and Regenerative Medicine" session at ARVO meeting (May 3)
  • 2011 - Moderator "Corneal Wound Healing Signal Transduction" session at the) meeting (May 2)
  • 2011 - NIH Special Emphasis Panel/Scientific Review Panel (ZRG1 MDCN-J 54R; (Mar 17-18)
  • 2011 - Poster received 1st place award at the 34th Annual Phi Zeta Research Day (Ben Yarnall; Mar 18)
  • 2011 - Paper received 2nd place award at the 34th Annual Phi Zeta Research Day (Ann Bosiack, Mar 18)
  • 2011 - Invited talk at the International Asia-ARVO meeting in Singapore (Jan 18-23)
  • 2011 - Organizer and Chair of the Nanotechnology session at the Asia-ARVO, Singapore (Jan 21)
  • 2011 - Invited speaker at the International Nanomedicine Conference in Sydney, Australia (Jul 14-16)

2010

  • 2010 - Poster #113 received 3rd place Basic Science-I Award at MU Health Research Day (Nov 11)
  • 2010 - Invited talk at the International Society for Eye Research (ISER), Montreal, Canada (July 19)
  • 2010 - Platform Corneal Stroma" session organizer/chair at ISER meeting, Montreal, (July 19)
  • 2010 - Invited lecture at World Ophthalmology Congress Berlin Germany
  • 2010 - American Society of Cataract and Refractive Surgery Foundation Research Award (Chetan Soni)
  • 2010 - US Army Medical Research study section (Adhoc)
  • 2010 - Best Paper Award, 17th annual Mason Eye Institute Research Day (Pam D'Souza, May 22)
  • 2010 - Best Paper Runners-up Award, 17th annual Mason Eye Research Day (Nate Hesemann, May 22)
  • 2010 - Abstract #434 selected as "the newest and most innovative research" and "Emerging Trends and Hot Topics" by Association for Research in Vision and Ophthalmology (ARVO)
  • 2010 - Moderator, ARVO Nanotechnology (Drug and gene delivery) session (May 02)
  • 2010 - Missouri Foundation for Medical Research Award to poster (Ajay Sharma, April 29)
  • 2010 - Department of Defense Study section (Polytrauma and Blast Injury) (April 19-21)
  • 2010 - University of Missouri Clinical and Translational Grant Reviewer (Adhoc)
  • 2010 - Abstract #367 received National Eye Institute, NIH Travel Award
  • 2010 - Abstract #433 received National Eye Institute, NIH Travel Award
  • 2010 - Abstract #434 received ARVO Travel Award
  • 2010 - Abstract #2839 received MUPA Travel Award from University of Missouri
  • 2010 - ARVO Organizing Committee (Nanotechnology and Nanomedicine)
  • 2010 - ARVO Annual Program Planning Committee (Nanotechnology and Nanomedicine)

2009

  • 2009 - ARVO Abstract #2415 received Santan Travel Award from ARVO
  • 2009 - NIH Study section Reviewer (ZRG1 BST-M), Bethesda, MD (Adhoc)
  • 2009 - Spurgeon Award Selection Committee, University of Missouri-Columbia
  • 2009 - Editorial Board of journal Nanomedicine: Nanotechnology, Biology and Medicine
  • 2009 - MUPA Travel Award from University of Missouri to abstract (Dylan
  • 2009 - Poster received 2nd place Award at Phi Zeta Research Day, MU Veterinary School Research day
  • 2009 - ARVO Organizing Committee Member (Nanotechnology and Nanomedicine)
  • 2009 - ARVO Annual Program Planning Committee
  • 2009 - Poster #44 received 1st place Basic Science-I Award at MU Health Research Day (Nov 12)
  • 2009 - Poster #93 received 2nd place Basic Science-II Award at MU Health Research Day (Nov 12)
  • 2009 - Poster #30 received 3rd place Basic Science-I Award at MU Health Research Day (Nov 12)
  • 2009 - Moderator "Step-by-step approach to infectious keratitis" session Asia-ARVO, India (Jan 16).
  • 2009 - ARVO Advocacy day organized by the NAVER, Rockville, MD (Jan 23)
  • 2009 - Moderator "Nanotechnology" paper session at ARVO, Ft. Lauderdale, Florida (May 04).

2008

  • 2008 - Editorial Board of journal of Refractive Surgery
  • 2008 - American Institute of Biological Sciences Grant Reviewer, New York, NY (Adhoc)
  • 2008 - Clinical and Translational Grant Reviewer University of Missouri (Adhoc)
  • 2008 - Grant Reviewer Panel of the Sultan Qaboos University, Oman
  • 2008 - Research Board Grant Reviewer, University of Missouri (Adhoc)
  • 2008 - Editorial Board of journal Cell Death
  • 2008 - ARVO Organizing Committee (Nanotechnology and Nanomedicine)
  • 2008 - ARVO Annual Program Planning Committee (Nanotechnology and Nanomedicine)
  • 2008 - ARVO Abstract Committee (Nanotechnology and Nanomedicine)
  • 2008 - Best Paper Runner-up Award, 15th Mason Eye Institute Research Day (Jun 8, Maneesh Mehan)
  • 2008 - Moderator "Nanotechnology and Nanomedicine" session ARVO, Ft. Lauderdale, Florida
  • 2008 - Moderator "Neovascularization" session ARVO meeting, Ft. Lauderdale, Florida
  • 2008 - Optic Nerve Rescue and Restoration meeting invitee, Glaucoma Foundation, New York
  • 2008 - International Faculty Travel Award from University of Missouri Research Council (May 20)

1982 - 2007

  • 2007 - Best Paper Award, 14th Mason Eye Institute Research Day (Jun 9, Maneesh Mehan)
  • 2007 - Moderator Ocular Cell and Molecular Biology meeting at Sarasota, Florida (Oct 6-9)
  • 2007 - Moderator "Neovascularization and Lymphangiogenesis" session, ARVO, Ft. Lauderdale, FL
  • 2005 - Best poster award by the Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • 2004 - Moderator "Corneal Wound Healing in Mice and Rats" ARVO, Ft. Lauderdale, Florida
  • 2002 - Best Show award, American Academy of Ophthalmology, San Francisco, California
  • 2000 - National Eye Institute Travel Award from NIH, Bethesda, Maryland
  • 1995 - SDRC travel award by the Skin Diseases Research Center, Cleveland, Ohio
  • 1985 - IDMA RESEARCH AWARD by the Indian Drug Manufacturers Association, Bombay, India
  • 1987-1990 - All India Merit Research Associate Fellowship, University Grants Commission, Delhi, India
  • 1984-1987 - Merit Senior Research Scholarship by the Council of Scientific & Industrial Research, India
  • 1982-1984 - Merit Junior Research Fellowship by the Council of Scientific & Industrial Research, India

Research Topics

  • Corneal gene therapy
  • Corneal wound healing
  • Refractive laser surgery (PRK, LASIK)
  • Corneal scarring and angiogenesis
  • Nanomedicine and nanoparticles
  • Growth factors/cytokines/receptors, apoptosis

Trauma, injury and/or infection to the eye lead to corneal scarring and/or neovascularization affectting approximately 1.5 million Americans each year. This highlights the importance of improving current therapies, and developing newer therapies for treating corneal diseases. Dr. Mohan's laboratory is attempting to define novel tissue-selective controlled viral and nonviral gene therapy approaches for corneal diseases and dystrophies using AAV- and nanotechnology-based vectors. His laboratory has identified several vectors (adeno-associated virus, lentivirus, plasmid and hybrid nanoparticles), optimized minimally invasive topical and microinjection vector delivery techniques and various combinations of vector and vector-delivery techniques to introduce therapeutic genes selectively into the stroma of normal and diseased corneas in vivo using animal models. In addition, his laboratory is investigating the safety and efficacy of various therapeutic genes for treating corneal diseases such as corneal scarring and angiogenesis utilizing newly defined controlled gene therapy modalities and rabbit as well as rodent models.

Photorefractive keratectomy (PRK) and laser-assisted in situ keratomileusis (LASIK) laser surgeries are frequently used worldwide to treat refractive errors, corneal scars and corneal dystrophies. Although laser eye surgeries are safe and precise they are associated with complications. The common complications of PRK are haze, halos, regression, while LASIK can lead to dry eye, epithelial ingrowth and flap wrinkles. Multiple cytokines and growth factors as well as inflammatory cells have been shown to play an important role in corneal wound healing following laser injury. Disturbances in normal healing often lead to myofibroblast formation and haze development in the cornea. Dr. Mohan's laboratory is investigating molecular mechanisms and signaling pathways associated with corneal wound healing and are working to identify preventative and/or interventional strategies to further improve laser eye surgery outcomes.

Dr. Mohan’s research program is supported from the extramural funding from the National Eye Institute, National Institute of Health, Bethesda Maryland, Veteran Health Administration, Washington DC, American Society of Cataract and Refractive Surgery Foundation Fairfax Virginia, American College of Veterinary Ophthalmologists Vision for Animals Foundation, Meridian, Idaho, Dialysis Clinic Inc, Nashville, Tennessee etc.

Lab Members

  • Ajay Sharma, Ph.D., Research Assistant Professor
  • Jason Rodier, MD, Postdoctoral fellow
  • Ashish Tandon, Ph.D., Postdoctoral fellow
  • Jerry Leung, Graduate student
  • Madhurt Korampally, Graduate student
  • Jonathan Tovey, MD, Ophthalmology resident
  • Michael Waggoner, MD, Ophthalmology resident
  • Dustin McKnight, MD, Ophthalmology resident
  • Ann Bosiack, DVM, Veterinary Ophthalmology resident and Masters student
  • Kevin DOnnelly, DVM, Veterinary Ophthalmology resident and Masters student
  • Lucas T. Lenci, Medical student
  • Jennie M. Cook, Veterinary Medicine student
  • Audra Stallard, Undergrad Discovery Fellow
  • Ryan J. Koch, Undergrad Discovery Fellow
  • Chaitasi Naik, Undergrad student

Media

Mohan Recognized for Research on Nanomedical Eye Disease Treatments

COLUMBIA, Mo. — Rajiv Mohan, Ph.D., a professor in the University of Missouri School of Medicine’s Department of Ophthalmology, has been named a 2014 Silver Fellow by the Association for Research in Vision and Ophthalmology (ARVO) for his contributions to eye research, including nanomedicine therapies to treat corneal diseases. He will be honored at the 2014 ARVO annual meeting May 8 in Orlando, Fla.

Mohan, who also serves as the Ruth M. Kraeuchi Endowed Professor in Veterinary Ophthalmology in the MU College of Veterinary Medicine, was recognized for his accomplishments in eye research, in addition to his leadership and contributions to the ophthalmology association. He has published more than 100 peer-reviewed articles and six book chapters, and he has presented his work at national and international eye research conferences. Mohan received his doctorate degree in medicinal chemistry from the University of Lucknow in India.

The Association for Research in Vision and Ophthalmology is the world’s largest eye and vision research organization with more than 12,750 members from more than 80 countries. Its mission is to facilitate the advancement of vision research and the prevention and cure of vision disorders worldwide.

View the official press release here

Association for Research in Vision and Ophthalmology (ARVO) identified research abstract (# 3294) as the "Newest and most innovative research" for 2012 annual meeting in Fort Lauderdale Florida, and published it in "Emerging Trends and Hot Topics". ARVO is the largest international eye research organization with more than 12,500 members from over 70 countries.
View PDF...

Dr. Kevin Donnelly received second place best presentation award in combined poster and paper presentation categories at the 35th Annual Phi Zeta University of Missouri College of Veterinary Medicine Research Day (May 4).
Read more...

Audra Stallard won “Outstanding Discovery Fellow Award” from the Honors College of University of Missouri-Columbia. Title of project: Corneal gene therapy studies Read more...

Jason Rodier MD, Postdoctoral fellow, received National Eye Institute NIH Travel Award to present his research at annual ARVO meeting (May-6-10) Ft. Lauderdale, Florida (Title: Polyethyleneimine (PEI) nanoparticle-mediated soluble TGFβRII gene transfer prevents corneal fibrosis. Read more...

Ashish Tandon, Ph.D., postdoctoral fellow, received “People’s Choice Best Poster Award” from the Missouri Foundation for Medical Research Columbia Missouri at the Harry S Truman Veterans Memorial Hospital 3rd Annual Research day (April 26). Title: Peritoneal fibrosis inhibition by decorin gene therapy given via hybrid nanoparticles or adeno-associated virus. Read more...

Jason Rodier, MD, postdoctoral fellow, received “Young Investigator Award” from the Missouri Foundation for Medical Research Columbia Missouri at the Harry S Truman Veterans Memorial Hospital 3rd Annual Research day (April 26). Title: Fuchs dystrophy: in vitro model development for studying disease pathology. Read more...

Distinguished Invited Lecture delivered at the Central Drug Research Institute, Lucknow, India.
View PDF...

The ARVO-International Society for Ocular Cell Biology organizing committee selected Dr. Mohan for an invited talk for the "Stem Cell Biology and Therapy" session of its biennial meeting in Vancouver Canada (Sept 7-10, 2011).
View PDF...

Sydney 2011 International Nanomedicine Conference scientific committee identified Dr. Mohan as an invited speaker for nanomedicine and regenerative research meeting in Sydney Australia (July 14-16, 2011).
Read more...

Association for Research in Vision and Ophthalmology (ARVO) selected Dr. Mohan's AAV-mediated decorin gene therapy for corneal scarring research abstract (# 3045) as the "Newest and most innovative research" in the Cornea section and identified in "Emerging Trends and Hot Topics" at the annual ARVO meeting in Ft. Lauderdale Florida (May 1-5, 2011). ARVO is the largest eye research organization of America with more than 12,500 members from over 70 countries.
View PDF...

The National Eye Institute, NIH selected Eric Hansen (medical student) research abstract (#......) on nanotechnology-mediated corneal gene therapy for Travel Awards for presenting research at an annual ARVO meeting in Ft. Lauderdale Florida (May 1-5, 2011). Read more...

Missouri Foundation for Medical Research awarded "Young Investigator Award" to Jonathan Tovey, MD for his research project demonstrating inhibition of corneal fibrosis by epigenetic modulation in rabbit model. Dr. Tovey is postdoctoral fellow and has completed these studies under mentorship of Dr. Mohan.
Read more...

Vet School Spotlight News
View PDF...

World Ophthalmology Congress Brings MU Discoveries Into Focus Nanomedicine research could help millions suffering from corneal conditions
Read more...

Association for Research in Vision and Ophthalmology (ARVO) recognized nanoparticle-mediated gene transfer abstract (#434) as "the newest and most innovative research" in Nanotechnology session and featured in "Emerging Trends and Hot Topics" during 2010 annual meeting in Fort Lauderdale, Florida. ARVO is the largest eye research organization of America with more than 12,500 members from over 60 countries
View PDF...

The National Eye Institute, NIH selected research abstracts on corneal scarring (#367) and corneal endothelial gene therapy (#433) among 1600 eligible abstracts for Travel Awards for presenting research at an annual ARVO meeting in Ft. Lauderdale Florida (May 2-6, 2010).
Read more...
Continue...

Abstract (#434) showing nanoparticle-mediated gene transfer in the normal and diseased rabbit cornea received 2010 ARVO Travel Award. Two travel awards are given each year by the ARVO for presenting research at its annual meeting in Ft. Lauderdale Florida.
Read more...
Continue...

Modulation of corneal angiogenesis by Enalpril research received 2010 Missouri Foundation for Medical Research Young Investigator Award.
Read more...

Three posters presenting research on corneal angiogenesis, nanomedicine and gene therapy received Best Paper Awards in Basic Science categories at Annual MU Health Sciences Research Day, University of Missouri-Columbia
Read more...

Equine gene transfer research was recognized at the Phi Zeta 32nd annual Research Day on March 13, 2009 at the College of Veterinary Medicine, MU.
Read more...

Equine corneal scarring research featured in "Spotlight in Research" of the MU College of Veterinary Medicine. The American College of Veterinary Ophthalmology Vision for Animals Foundation awarded grant for the development of an in vitro model for studying and identifying newer drugs to treat corneal scarring in horses.
View PDF...

Corneal endothelial gene transfer research received 2010 MUPA Travel award
Read more...

A potential of treating corneal scarring in horses with mitomycin C featured in University of Missouri College of Veterinary Medicine "Spotlight in Research" in Jan 2010
View PDF...

Interview with Walter Bethke, Managing Editor, for Review of Ophthalmology (Vol. 13:11, Nov. 2006)
Read more...

Kahuku High School, Hawaii recognized Dr. Jonathan Tovey, who is learning translational and basic science skills under mentorship of Dr. Mohan at MU
Read more...

American College of Veterinary Opthalmologists Vision for Animals Foundation entitled "Mitomycin C a potent inhibitor of fibrosis in the equine cornea: Role: Co-Principal Investigator (PI Dr. Dylan Buss, fellow in lab); $5000
Read more...

Photos

Mohan1Small
Mohan Lab Group
Mohan2Small
Department Friends and Colleagues
Mohan3Small

Mohan4Small

Mohan5Small
Dr. Mohan and Jonathan Tovey
Mohan6Small

Mohan7Small

Mohan8Small

Mohan9Small
2012 ARVO
Mohan -2010-arvoawardees
2010 ARVO Awardees
MohanSM2010-MU Researchday
2010 MU Research Day
MohanSM-2010-Worldophthalmology congress-berlin
2010 World Ophthalmology Congress, Berlin
Mohan2011arvo
2011 ARVO
MohanSM2011Asia-ARVO-1-Singapore
2011 ARVO, Singapore
MohanSM2011-Asia-ARVOSingapore
2011 ARVO, Singapore
MohanSM2011-Daekin UniversityAustralia
2011, Daekin University, Australia
MohanSM2011Iser meeting Montreal
2011 Iser Meeting, Montreal
MohanSM2011MFMR award
2011 MFMR Award
MohanSM2011nanomedicine conference-Sydney
2011 Nanomedicine Conference, Sydney
MohanSM2011-OCMB-meetingVancouver
2011 OCMB Meeting, Vancouver
MohanSM2011-OCMB-meeting-Vancouver
2011 OCMB Meeting, Vancouver
Mohan2011-US Senate
2011 - U.S. Senate
MohanSM2012-arvo-1
2012 ARVO
MohanSM2012-ARVO-2
2012 ARVO
MohanSM2012-ARVO-Hot-topic
2012 ARVO, Hot Topic
MohanSM2012-ARVO-JT-RRM
2012 ARVO, Jason Rodier
MohanSM2012-Discovery fellow award-Audra
2012 Discovery Fellow Award - Audra
MohanSM2012-Discovery fellow
2012 Discovery Fellow Awards
MohanSM2012-MFMR-Young Investigator award-Jason
2012, Jason Rodier
MohanSM2012-world-ophthalmology-congress-abudhabi-3
2012, World Ophthalmolgy Congress - Abu Dhabi
MohanSM2012-Worl-Ophthalmology congress-abudhabi-1
2012, World Ophthalmolgy Congress - Abu Dhabi
MohanlabSM-pic-1
Mohan Lab Group
MohanlabSM-pic-2
Mohan Lab Group
MohanlabSM-pic-3
Mohan Lab Group
Mohanlabpic-4
Mohan Lab Group
Mohan2012-MFMR-People choice award
2012, MFMR People's Choice Award

Publications

Peer-reviewed Published Journal Articles

  1. Tandon A, Tovey JCK, Waggonor MR, A, Sharma A, Cowden JW, Gibson DJ, Liu Y, Schultz GS, Mohan RR. Vorinostat: A potent agent to treat laser-induced corneal haze. J Refract Surg. 2012;28:285-290.
  2. Korampally M, Apperson SJ, Staley CS, Castorena JA, Thiruvengadathan R, Gangopadhyay K, Mohan RR, Ghosh A, Polo-Parada L, Gangopadhyay S. Transient pressure mediated intranuclear delivery of FITC-Dextran into chicken cardiomyocytes by MEMS-based nanothermite reaction actuator. Sensors and Actuators B: Chemical. 2012 http://dx.doi.org/10.1016/j.snb.2012.06.081,
  3. Liu J, Seet LF, Koh LW, Venkatraman A, Venkataraman D, Mohan RR, Praetorius J, Bonanno JA, Aung T, Vithana EN. Depletion of SLC4A11 causes cell death by apoptosis in an immortalized human corneal endothelial cell line. Invest Ophthalmol Vis Sci. 2012;53:3270-3279.
  4. Mohan RR, Rodier JT. Corneal gene therapy: Principles and Potential. Book titled Principles and Practice of Cornea, Editors: Robert Copeland Jr and Natalie Afshari. Jaypee Brothers Medical Publisher, New Delhi, India 2012 In press.
  5. Rodier JT, Tandon A, Sharma A, Mohan RR. Corneal gene therapy: Basic science and Translational prospective: Ocular Surface J 2012 In press.
  6. Mohan RR, Tovey JCK, Sharma A, Tandon A. Gene Therapy in the Cornea: 2005-present. Progress in Retinal and Eye Research 2012; 31:44-64
  7. Tandon A, Rodier JT, Sharma A, KleibanovAM, Mohan RR. Gold Nanoparticle-mediated Targeted BMP7 Gene Delivery Into Rabbit Stroma Inhibits Corneal Fibrosis in vivo via Smad modification. Nanomedicine 2012 In press.
  8. Bosiack AP, Giuliano EA, Gupta R, Mohan RR. Corneal Gene Therapy in veterinary medicine: A review. J Veterinary Science Technology 2012, S8 http://dx.doi.org/10.4172/2157-7579.S8-001
  9. Bosiack AP, Giuliano EA, Gupta R, Mohan RR. Canine corneal fibroblast and myofibroblast transduction with AAV5. Vet Ophthalmol. 2011 Dec 13. doi: 10.1111/j.1463-5224.2011.00980.x.
  10. SharmaA, Rodier JT, TandonA, KleibanovAM, Mohan RR. Nanoparticle-driven soluble transforming growth factor-β type II receptor gene transfer inhibits corneal fibrosis. Mol Vis 2012 In press
  11. Bosiack AP, Giuliano EA, Gupta R, Mohan RR. Efficacy and safety of suberoylanilide hydroxamic acid (Vorinostat) in the treatment of canine corneal fibrosis. Vet Ophthalmol. 2011. Dec 29. doi: 10.1111/j.1463-5224.2011.00985.x.
  12. Tovey JCK, Buss D, Gupta R, Tandon A, Sharma A, Hauswirth WW, Chiodo V, Cowden JW, Mohan RR. Remarkably high and targeted transgene delivery into mouse corneal endothelium in vivo with tyrosine-mutant AAV8. Manuscript under preparation.
  13. Mohan RR, Tovey JCK, Sharma A, Schultz GS, Cowden JW, Tandon A. Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo. PLoS One 2011; 6:e26432.
  14.  Kanwar JR, Sun X, Punj V, Sriramoju B, Mohan RR, Zhou SF, Chauhan A, Kanwar RK. Nanoparticles in the treatment and diagnosis of neurological disorders: Untamed dragon with fire power to heal. Nanomedicine. 2011 Sept 1 doi:10.1016/j.nano.2011.08.006.
  15. Gupta R, Benjamin W. Yarnall, Elizabeth A. Giuliano, Jagat R. Kanwar, Dylan G. Buss, Mohan RR. Mitomycin C: a promising agent for the treatment of canine corneal scarring. Veterinary Ophthalmology. 2011; 14:304-3212.
  16. Mohan RR, Tandon A, Sharma A, Cowden JW, Tovey JCK. Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy. Invest Ophthalmol Vis Sci. 2011; 52:4833-4841.
  17. Mohan RR, Sinha S, Tandon A, Gupta R, Tovey JCK, Sharma A. Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea. PLoS One. 2011; 6(4):e18771.
  18. Mohan RR, Tovey JCK, Gupta R, Tandon A, Sharma A. Decorin biology, expression, function and therapy in the cornea. Curr. Mol. Med. 2011, 11:110-128.
  19. SharmaA, TandonA, Jonathan JCK, GuptaR, RobertsonD, FortuneFA, KleibanovAM, CowdenJW, Mohan RR. Polyethyleneimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea. Nanomedicine: Nanotechnology, Biology and Medicine. 2011; 7(4):505-513.
  20. Tandon A, Tovey JCK, Mohan RR. Gene therapy for corneal diseases. 2011, pp 47-63. Nova Science Publishers, Inc., Hauppauge, NY.
  21. Mohan RR, Sharma A, Cebulko TC, Tandon A. Vector-delivery techniques regulate AAV-mediated gene transfer in the cornea in vivo. Mol Vis 2010, 16:2494-2501.
  22. Kanwar JR, Mohan RR, Kanwar RK, Roy K, Bawa R. Application of aptamer in nanodelivery systems in cancer, eye and inflammatory diseases. Nanomedicine, 2010, 5:1435-1445.
  23. Kitano A, Okada Y, Yamanda O, Shirai K, Mohan RR, Saika S. Therapeutic potential of Trichostatin-A to control inflammatory and fibrogenic disorders of ocular surface. Mol. Vis. 2010, 16:2964-2973.
  24. Sharma A, Tovey JCK, Ghosh A, Mohan RR. AAV serotype influences gene transfer in corneal stroma in vivo. Exp Eye Res 2010, 91:440-448.
  25. Tandon A, Tovey JCK, Sharma A, Gupta R, Mohan RR. Role of transforming growth factor-beta in corneal function, biology and pathology. Curr Mol Med. 2010, 10: 565-578.
  26. Mohan RR, Gupta R, Mehan MM, Cowden JW, Sinha S. Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts. Exp Eye Res. 2010, 91:238-245.
  27. Sharma A, Bettis DI, Cowden JW, Mohan RR. Localization of angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivo. Mol Vis. 2010, 16:720-28.
  28. Sharma A, Ghosh A, Hansen ET, Newman JM, Mohan RR. Transduction efficiency of AAV 2/6, 2/8 and 2/9 vectors for delivering genes in human corneal fibroblasts. Brain Research Bulletin. 2010, 81:273-78.
  29. Buss D, Sharma A, Giuliano E, Mohan RR. Isolation and cultivation of equine corneal keratocytes, fibroblasts and myofibroblasts. Vet Ophthalmol. 2010, 13:37-42.
  30. Sharma A, Ghosh A, Siddappa C, Mohan RR. Gene Therapy for the cornea, conjunctiva, and lacrimal gland. Encyclopedia of the Eye. 2010, 2:185-194.
  31. Buss D, Sharma A, Giuliano EA, Mohan RR. Efficacy and safety of Mitomycin C as an agent to treat corneal scarring in horses using an in vitro model. Vet Ophthalmol. 2010, 13:211-218.
  32. Buss D, Sharma A, Giuliano E, Mohan RR. Gene delivery in the equine cornea: a novel therapeutic strategy. Vet Ophthalmol. 2010, 13:301-306.
  33. Thakkar MM, Engemann SC, Sharma R, Mohan RR, Sahota P. Sleep-wakefulness in alcohol preferring (P) and non-preferring (NP) rats following binge alcohol administration. Neuroscience. 2010, 170:22-27
  34. Tandon A, Tovey JCK, Mohan RR. Gene therapy for corneal diseases. 2011, pp 47-63. Nova Science Publishers, Inc., Hauppauge, NY (https://www.novapublishers.com/catalog/product_info.php?products_id=23067)
  35. Kanwar JR, Sun, X, Punj V, Mohan RR, Shufeng Z, Kanwar RK. Applications of conjugated and unconjugated nanoparticles in neurological and corneal diseases. Nano Letters In press.
  36. Gupta D, Arora R, Mohan RR, Almasan A, Gudkov AV, Macklis RM. Novel Strategies for Protecting Mitochondria (the Cellular Powerhouse) Against Low-LET Radiation. Herbal Radiomodulators. 2009, 215-226.
  37. Sharma A, Mehan MM, Sinha S, Cowden JW, Mohan RR. Trichostatin A inhibits corneal haze in vitro and in vivo. Invest Ophthalmol Vis Sci. 2009, 50:2695-701
  38. Medeiros FW, Mohan RR, Chaurasia S, Sinha S, Stapleton WM, Rayborn M, Wilson SE. Haze Development after Photorefractive Keratectomy: Mechanical vs. Chemical Epithelial Removal. J. Refractive Surgery 2008, 24:923-927.
  39. Vij N, Sharma A, Thakkar MM, Sinha S, Mohan RR. PDGF-driven proliferation, migration, and IL8 chemokine secretion in human corneal fibroblasts involve JAK2-STAT3 signaling pathway. Mol Vis 2008, 14: 1020-1027.
  40. Stapleton WM, Chaurasia S, Medeiros FW, Mohan RR, Sinha S, Wilson SE. Topical interleukin-1 receptor antagonist inhibits inflammatory cell infiltration in cornea. Exp Eye Res. 2008, 86:753-757.
  41. Mohan RR, Stapleton WM, Sinha S, Netto NV, Wilson SE. A novel method for generating corneal haze in anterior stroma of the mouse eye with the excimer laser. Exp Eye Res 2008, 86:235-240.
  42. Netto MV, Mohan RR, Dupps W Jr, Sinha S, Krueger RR, Stapleton WM, Medeiros, Rayborn M, Wilson SE. Femtosecond laser and microkeratome LASIK flaps: Comparison of stromal wound healing and inflammatory infiltration in the cornea. J. Refractive Surgery 2007, 23:667-676.
  43. Guerriero E, Chen J, Sado Y, Mohan RR, Wilson SE, Funderburgh JL, Sundarraj N. Loss of alpha3 (IV) collagen expression associated with corneal keratocyte activation. Invest Ophthalmol Vis Sci. 2007, 48:627-635.
  44. Netto MV, Mohan RR, Sinha S, Sharma A, Gupta PC, Wilson SE. Effect of prophylactic and therapeutic Mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits. J. Refractive Surgery. 2006, 22: 562-574.
  45. Netto MV, Mohan RR, Sinha S, Sharma A, Dupps W Jr, Wilson SE. Stromal haze, myofibroblasts, and surface irregularity after PRK. Exp Eye Res. 2006, 82:788-797.
  46. Mohan RR, Sharma A, Netto MV, Sinha S, Wilson SE. Gene therapy in the cornea. Prog Retin Eye Res.  2005, 24, 537-559.
  47. Netto MV, Mohan RR, Ambrosio R, Wilson SE. Wound healing in the cornea: a review of refractive surgery complications and new prospects for therapy.  Cornea. 2005, 24: 509-522.
  48. Wilson SE, Mohan RR, Netto M, Perez V, Possin D, Huang J, Kwon R, Alekseev A, Rodriguez-Perez JP. RANK, RANKL, OPG, and M-CSF expression in stromal cells during corneal wound healing. Invest Ophthalmol Vis Sci. 2004, 45:2201-2211.
  49. Wilson SE, Mohan RR, Ambrosio R, Mohan RR. Corneal injury. A relatively pure model of stromal-epithelial interactions in wound healing. Methods Mol Med. 2003, 78:67-81.
  50. Mohan RR, Schultz GS, Hong J-W, Mohan RR, Wilson SE: Gene transfer into rabbit kerato­cytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access Exp Eye Res. 2003, 76:373-383.
  51. Wilson SE, Mohan RR, Hutcheon AEK, Mohan RR, Ambrósio R, Zieske JD, Hong JW, Lee J-S. Effect of ectopic epithelial tissue within the stroma on keratocyte apoptosis, mitosis, and myofibroblast transformation. Exp Eye Res 2003;76 :193-201.
  52. Mohan RR, Hutcheon AEK, Choi R, Hong J-W, Lee J-S, Mohan RR, Ambrósio R, Zieske JD, Wilson SE:  Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Exp Eye Res 2003:76:71-87.
  53. Mohan RR, Possin DE, Mohan RR, Sinha S, Wilson SE: Development of Genetically Engineered tet HPV16-E6/E7 Transduced Human Corneal Epithelial Clones Having Tight Regulation of Proliferation and Normal Differentiation. Exp Eye Res 2003; 77:395-407.
  54. Wilson SE, Mohan RR, Hong J, Lee J, Choi R, Liu JJ, Mohan RR. Apoptosis in the cornea in response to epithelial injury: significance to wound healing and dry eye. Adv Exp Med Biol. 2002, 506:821-826.
  55. Hong J-W, Liu JJ, Mohan RR, Mohan RR, Woods DJ, He YG, Wilson SE. Proinflammatory chemokine induction in keratocytes and inflammatory cell infiltration into the cornea. Invest Ophthalmol Vis Sci. 2001: 42:2795-2803.
  56. Wilson SE, Mohan RR, Mohan RR, Ambrosio R, Hong J, Lee J. The Corneal Wound Healing Response: Cytokine-mediated Interaction of the Epithelium, Stroma, and Inflammatory Cells. Prog Retin Eye Res. 2001: 20:625-637.
  57. Wilson SE, Mohan RR, Hong JW, Lee JS, Choi R, Mohan RR. The wound healing response after laser in situ keratomileusis and photorefractive keratectomy: elusive control of biological variability and effect on custom laser vision correction. Arch Ophthalmol. 2001: 119:889-896.
  58. Mohan RR, Mohan RR, Wilson SE. Discoidin domain receptor (DDR) 1 and 2: collagen-activated tyrosine kinase receptors in the cornea. Exp Eye Res. 2001: 72:87-92.
  59. Kim WJ, Mohan RR, Mohan RR, Wilson SE. Caspase inhibitor z-VAD-FMK inhibits keratocyte apoptosis, but promotes keratocyte necrosis, after corneal epithelial scrape. Exp Eye Res. 2000: 71:225-232.
  60. Mohan RR, Mohan RR, Kim W-J, and Wilson SE: Modulation of TNF alpha-induced apoptosis in corneal fibroblasts by transcription factor NF-kB. Invest.Ophthalmol.and Vis.Sci. 2000: 41(6):1327-1336.
  61. Mohan RR, Mohan RR, Kim W-J, Stark GR and Wilson SE: Defective keratocyte apoptosis in response to epithelial injury in Stat-1 Null mice. Exp Eye Res. 2000; 70:485-491.
  62. Kim WJ, Helena MC, Mohan RR, Wilson SE. Changes in corneal morphology associated with chronic epithelial injury. Invest Ophthalmol Vis Sci. 1999: 40(1):35-42.
  63. Kim W-J, Mohan RR, Mohan RR, and Wilson SE: Effect of PDGF, IL-1 alpha and BMP2/4 on corneal fibroblasts chemotaxis: Expression of platelet-derived growth factor system. Invest.Ophthalmol Vis.Sci. 1999; 40:1364-1372.
  64. Gupta S, Ahmed N, Mohan RR, Husain MM and Mukhtar H: Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase: Cancer Res. 1999; 59:2115-2120.
  65. Wilson SE, Liu J J and Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res. 1999; 18(3):293-309.
  66. Wilson SE, Chen L, Mohan RR, Liang Q, Liu J: Expression of HGF, KGF, EGF and receptor messenger RNAs following corneal epithelial wounding. Exp Eye Res. 1999; 68(4):377-397.
  67. Mohan RR, and Wilson SE: Ex vivo human corneal epithelial cells express membrane-bound precursor and mature soluble epidermal growth factor (EGF) and transforming growth factor alpha (TGF alpha) proteins. Exp Eye Res. 1999; 68(1):129-131.
  68. Lahiri-Chatterjee, M, Katiyar SK, Mohan RR, and Agarwal R: A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. Cancer Res. 1999; 59(3):622-632.
  69. Mohan RR, Challa A, Gupta S, Bostwick DG, Ahmed N, Agarwal R, Marengo SR, Amini SB, Paras F, Maclennan GT, Resnick MI and Mukhtar H: Overexpression of ornitheine decarboxylase in prostate cancer and prostatic fluid in humans. Clin Cancer Res. 1999; 5(1):143-147.
  70. Mohan RR, Kim W-J, Mohan RR, Chen L and Wilson SE: Bone morphogenic proteins 2 and 4 and their receptors in the adult human cornea. Investigative Ophthalmol. and Vis Sci. 1998; 39(13):2626-2636.
  71. Wilson SE, Li Q, Mohan RR, Tervo T, Vesaluoma M, Bennett GL, Schwall R, Tabor K, Kim J, Hargrave S and Cuevas KH: Lacrimal gland growth factors and receptors: lacrimal fibroblastic cells are a source of tear HGF. Adv Exp Med Biol. 1998; 438:625-628.
  72. Liang Q, Mohan RR, Chen L and Wilson SE: Signaling by HGF and KGF in corneal epithelial cells: Ras/ MAP Kinase and Jak-STAT pathways. Investigative Ophthalmol. and Vis Sci. 1998; 39(8):1329-1338.
  73. Weng J, Mohan RR, Li, Q and Wilson SE: IL-1 Upregulates keratinocyte growth factor and hepatocyt growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-1beta expression in the cornea. Cornea. 1997; 16(4):465-471.
  74. Weng J, Liang Q, Mohan RR, Li Q and Wilson SE: Hepatocyte growth factor, keratinocyte growth factor-receptor systems in the lens. Investigative Ophthalmol. and Vis Sci.  1997; 38(8):1543-1554.
  75. Mohan RR, Liang Q, Kim WJ, Helena MC, Baerveldt F and Wilson SE: Apoptosis in the cornea: Further characterization of Fas/Fas ligand system. Exp Eye Res. 1997; 65:575-589.
  76. Katiyar SK, Mohan RR, Agarwal R and Mukhtar H: Protection against induction of mouse skin papillomas with low- and high- risk for conversion to malignancy by green tea polyphenols. Carcinogenesis. 1996; 18: 497-502.
  77. Singh SV, Mohan RR, Agarwal R, Benson PJ, Hu X, Rudy MA, Xia H, Katoh A, Srivastava SK, Mukhtar H, Gupta V and Zaren HA: A novel anti-carcinogenic activity of an organosulfide from garlic: inhibition of H-ras oncogene transformed tumor growth in vivo by diallyl disulfide is associated with inhibition of p21 H-ras processing. Biochem. Biophy Res Comm. 1996; 225:660-665.
  78. Agarwal R, Mohan RR, Ahmed N and Mukhtar H :Protection against malignant conversion in SENCAR mouse skin by all trans retinoic acid: inhibition of ras p21 processing enzyme farnesyltransferase and Ha-ras p21 membrane localization. Mol Carcinogenesis. 1996; 17:13-22.
  79. Li Q, Weng J, Mohan RR, Bennett GL, Schwall R, Wang Z, Tabor K, Kim J, Hargrave S Cuevas KH and Wilson SE: Hepatocyte growth Factor (HGF) and HGF receptor protein in lacrimal gland, tears and cornea. Investigative Ophthalmol. and Vis Sci. 1996; 37 (5):727-739.
  80. Mohan RR, Katiyar SK, Khan S. G. Mukhtar H and Agarwal R: Protective effects of all trans retinoic acid against tumor promotion and progression in low- and high-risk protocols of mouse skin chemical carcinogenesis. International J. Oncology. 1996; 8:1079-1088.
  81. Agarwal R, Korman NJ, Mohan RR, Jawed S, Zaim MT and Mukhtar H: Apoptosis is an early event during phthalocyanine-photodynamic therapy-induced ablation of murine skin tumors. Photochem Photobiol. 1996; 63:547-552.
  82. Khan SG, Mohan RR, Katiyar SK, Wood, GS, Bikers DR, Mukhtar H and Agarwal R: Mutations in ras oncogenes are rare event in ultraviolet B radiation induced mouse skin tumorigenesis. Mol Carcinogenesis. 1996; 15:96-103.
  83. Mohan RR. Synthesis of quinazolinyl-benzylidene hydrazides and methyl benzylidene-hydrazides as CNS active and anti-inflammatory agents. J Ind Council Chem. 1992; 9:58-61.
  84. Mohan RR. Synthesis of thiazolidinyl-benzylidene/methyl benzylidene-hydrazides and their Mannich bases as CNS active and anti-inflammatory agents. Indian Drugs. 1991; 29:120-122.
  85. Srivastava M and Mohan RR. Synthesis of 2-thio-3-aryl amino methyl-4-oxo-5-[4-{2-substituted-4-(3,4-disubstituted benzylidene)-5-oxo-imidazolyl}-a-methyl benzylidene] thiazolidenes as CNS active and anti-inflammatory agents. Indian Drugs. 1989; 26:342-347.
  86. Sinha S, Saxena A and Mohan RR. Synthesis of 1-(2/9-substituted indophenazine-6-methyl carbonyl) 3-methyl-4-(substituted benzylidene/methyl benzylidene)-pyrazolin-5-ones as potent CNS and anti-inflammatory agents. Indian Drugs. 1988; 26:77-80.
  87. Agarwal R, Agarwal C, Singh C and Mohan RR, Misra VS: Synthesis of 6-substituted indophenazines as possible psychotropic and anti inflammmatory agents. Acta Pharm Jugosl. 1988; 38:11-21.
  88. Mohan RR and Misra VS: Synthesis and anthelmintic activity of 1-(substituted piperazino ethyl carbonyl phenyl-4-yl)-2-methyl /phenyl-4-(3,4-disustituted-benzylidene)-5-oxo-imidazoles. Indian Drugs. 1986; 23:418-422.
  89. Mohan RR, Agarwal R and Misra VS: Synthesis of 2/9-substituted indophenazin-6-acetic acid aryl/methyl benzylidene hydrazides, 4-aryl-1-(indophenazin-6-methylcarbonyl)-3-thiosemicarbazides and 6-(4-aryl-5-mercapto-4H-1,2,4-triazol-3yl-methyl indophenazines as CNS active and anti-inflammatory agents. Ind J Chem. 1986; 25B:1234-1237.
  90. Mohan RR, Agarwal C and Misra VS: Synthesis of some newer-4-(3-methyl-5-oxo-4-pyrazolidenemethyl) phenoxy acetic acid hydrazides and methyl benzylidene hydrazides as CNS active and anti-inflammatory agents. Ind J Chem. 1986; 25B:339-341.
  91. Singh A, Mohan RR, and Misra VS: Synthesis of1-aryl-3-[1-a-benzylidene-thiobarbituric acids (III) as CNS active agents. Indian Drugs. 1985; 22:418-422.
  92. Mohan RR, Agarwal R and Misra VS: Synthesis of some newer quinazolinyl-oxadiazoles, thiosemicarbazides and thiadiazoles as pharmacologically active agents. Ind J Chem. 1985: 24B:78-82.
  93. Mohan RR, Agarwal C and Misra VS: Synthesis and anthelmintic activity of 4-methyl-7-(substituted phenyl aminocarbonyl/disubstituted amino carbonyl) methoxy coumarins. Indian Drugs, 21, 389-392, 1984.
  94. Mohan RR, Agarwal C, Agarwal R and Misra VS: CNS, anthelmintic and anti-inflammatory activities of some 1-[2/3-(2-phenyl benzimidazole]-2-methyl/phenyl-4-(3,4-disubstituted benzylidene) 5-oxo-imidazoles. Pharm Res Comm, 1984; 16:321-338.
  95. Mohan RR, Agarwal R and Misra VS: Synthesis and pharmacological screening of 2-thio-3-arylaminomethyl-4-oxo-5-(3,4-disubstituted-benzylidene) thiazolidines. Indian Drugs. 1983; 21:90-95.

Invited Book Chapters

  1. Mohan RR, Rodier JT. Corneal gene therapy: Principles and Potential. Book titled Principles and Practice of Cornea, Editors: Robert Copeland Jr. and Natalie Afshari, Jaypee Brothers Medical Publisher, New Delhi, India 2012 In press.
  2. Tandon A., Tovey JCK, Mohan RR. Gene therapy for corneal diseases: Nova Publishers; Edited by Alan N. Westerhouse (pp 47-63), 2011.
  3. Sharma A, Ghosh A, Siddappa C, Mohan RR. Gene Therapy for the cornea, conjunctiva, and lacrimal   gland. Encyclopedia of the Eye. Oxford: Academic Press; Edited by Darlene A. Dartt, Vol 2, 185-194, 2010.
  4. Gupta D, Arora R, Mohan RR, Almasan A, Gudkov AV, Macklis RM. Novel Strategies for Protecting Mitochondria (the Cellular Powerhouse) Against Low-LET Radiation: A Review. CAB International,   Oxfordshire, UK. Herbal Radiomodulators: Applications in Medicine, Homeland Defense and Space   Edited by Dr. Rajesh Arora. P 215-226, 2009.
  5. Wilson SE, Mohan R, Mohan RR, Ambrósio R, Hong J-W, Lee JS: “The corneal wound heal­ing response: Cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells,” In:         DiPietro LA & Burns-Harring AL (eds.): Wound Healing Methods and Protocols. Copyright © 2001          Humana Press, Totowa, N.J.; vol. 20, pp. 625-37.
  6. Wilson SE, Li Q, Mohan RR, Tervo T, Vesaluoma M, Bennett GL, Schwall R, Tabor K, Kim J, Hargrave S and Cuevas KH: Lacrimal gland growth factors and receptors: lacrimal fibroblastic cells    are a source of tear HGF. Adv Exp Med Biol, 438, 625-628, 1998.
Printer Friendly Secure Secure        
Follow us on Twitter!   Facebook   YouTube Videos  
Website created and maintained by the Office of Communications. Contact the MU School of Medicine.
Revised: June 21, 2013 - Copyright © 2013 - The Curators of the University of Missouri.
All rights reserved. DMCA and other copyright information. An equal opportunity/affirmative action institution.